MONTREAL, QUEBEC -- (MARKET WIRE) -- September 28, 2006 -- Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases, announced today that it's President and Chief Executive Officer, Hans J. Mader, will present an overview of the Company at the BioContact Quebec 2006 Symposium to be held at Chateau Frontenac, Quebec City, from October 4-6, 2006. This presentation will take place on Thursday, October 5th, at 11:00 a.m. local time, in Salon Bellevue.
